Literature DB >> 17267025

Status of surgical treatment procedures for endometrial cancer in Japan: results of a Japanese Gynecologic Oncology Group survey.

Yoh Watanabe1, Daisuke Aoki, Ryo Kitagawa, Satoshi Takeuchi, Satoru Sagae, Noriaki Sakuragi, Nobuo Yaegashi.   

Abstract

OBJECTIVE: We investigated the current status of surgical procedures for endometrial carcinoma in Japan by surveying members of the Japan Gynecologic Oncology Group (JGOG).
METHODS: A mail survey focusing on hysterectomy procedures, indications for radical hysterectomy, methods for detecting pelvic (PEN) and para-aortic lymph node (PAN) status, and indications for PAN dissection/biopsy, was sent to all 215 authorized JGOG member institutions.
RESULTS: A total of 139 (57.2%) members responded to the survey. Abdominal total hysterectomy (TAH) was utilized by 35.3% of institutions and Piver class II extended hysterectomy by 30.2%. In 35.5% of institutions, hysterectomy procedures were selectively employed based on tumor-related factors. Radical hysterectomy (RH) was utilized by 29.5% of institutions; TAH was used significantly more frequently by specialist hospitals while RH was significantly less commonly utilized by specialist hospitals compared with university hospitals and general hospitals. PEN dissection was routinely utilized by 97.8% of institutions. In 93.5% of institutions, PAN dissection/biopsy was used either routinely (12.2%) or selectively based on tumor-related factors (81.2%). In 6.5% of institutions, PAN dissection/biopsy has never been employed.
CONCLUSION: The status of surgical procedures for the treatment of endometrial cancer is still not standardized. However, TAH, bilateral salpingo-oophorectomy, PEN dissection, and PAN dissection/biopsy in selected cases are recent surgical procedures used for the treatment of endometrial cancer in Japan. Clinical trials to determine the survival benefit of the different surgical procedures should be developed to determine the standard surgical procedures to be used for the treatment of endometrial cancer.

Entities:  

Mesh:

Year:  2007        PMID: 17267025     DOI: 10.1016/j.ygyno.2006.12.015

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  10 in total

1.  Survival advantage of lymphadenectomy in endometrial cancer.

Authors:  Holm Eggemann; Tanja Ignatov; Katharina Kaiser; Elke Burger; Serban Dan Costa; Atanas Ignatov
Journal:  J Cancer Res Clin Oncol       Date:  2016-01-08       Impact factor: 4.553

2.  Surgical practice patterns in endometrial cancer: results of the Korean Gynecologic Oncology Group survey.

Authors:  Taek Sang Lee; Jae Weon Kim; Sung Hoon Kim; Seok Ju Seong; Eun-Seop Song; Jae-Hoon Kim; Jong-Hyeok Kim; Noh-Hyun Park; Ki-Heon Lee; Nak-Woo Lee; Hee-Sug Ryu
Journal:  J Gynecol Oncol       Date:  2009-06-29       Impact factor: 4.401

3.  Risk factors for paraaortic lymph node metastasis in endometrial cancer.

Authors:  Mustafa Erkan Sari; İbrahim Yalcin; Hanifi Sahin; Mehmet Mutlu Meydanli; Tayfun Gungor
Journal:  Int J Clin Oncol       Date:  2017-05-18       Impact factor: 3.402

4.  Nationwide analysis on surgical procedures for patients with endometrial cancer in Germany: results of the AGO pattern of care studies from the years 2013, 2009, and 2006.

Authors:  Marco Johannes Battista; Marcus Schmidt; Nicole Rieks; Joscha Steetskamp; Isabel Sicking; Antje Lebrecht; Heinz Koelbl; Peter Mallmann; Gerald Hoffmann; Eric Steiner
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-02       Impact factor: 4.553

5.  Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 edition.

Authors:  Satoru Nagase; Hidetaka Katabuchi; Masamichi Hiura; Noriaki Sakuragi; Yoichi Aoki; Junzo Kigawa; Tsuyoshi Saito; Toru Hachisuga; Kiyoshi Ito; Takashi Uno; Noriyuki Katsumata; Shinichi Komiyama; Nobuyuki Susumu; Makoto Emoto; Hiroaki Kobayashi; Hirohito Metoki; Ikuo Konishi; Kazunori Ochiai; Mikio Mikami; Toru Sugiyama; Makio Mukai; Satoru Sagae; Hiroshi Hoshiai; Daisuke Aoki; Masahide Ohmichi; Hiroyuki Yoshikawa; Tsuyoshi Iwasaka; Yasuhiro Udagawa; Nobuo Yaegashi
Journal:  Int J Clin Oncol       Date:  2010-11-11       Impact factor: 3.402

6.  Necessity of radical hysterectomy for endometrial cancer patients with cervical invasion.

Authors:  Taek Sang Lee; Jae Weon Kim; Dae Yeon Kim; Young Tae Kim; Ki Heon Lee; Byoung Gie Kim; D Scott McMeekin
Journal:  J Korean Med Sci       Date:  2010-03-19       Impact factor: 2.153

7.  Selective lymphadenectomy in endometrial cancer: Retrospective analysis of morbidity and survival data at a tertiary care centre.

Authors:  Uzma Chishti; Aliya B Aziz; Munazza Akhtar; Sana Sheikh
Journal:  Pak J Med Sci       Date:  2015 Jul-Aug       Impact factor: 1.088

8.  Lymphadenectomy can be omitted for low-risk endometrial cancer based on preoperative assessments.

Authors:  Takashi Mitamura; Hidemichi Watari; Yukiharu Todo; Tatsuya Kato; Yosuke Konno; Masayoshi Hosaka; Noriaki Sakuragi
Journal:  J Gynecol Oncol       Date:  2014-06-18       Impact factor: 4.401

9.  Baseline risk of recurrence in stage I-II endometrial carcinoma.

Authors:  Shinsuke Sasada; Mayu Yunokawa; Yae Takehara; Mitsuya Ishikawa; Shunichi Ikeda; Tomoyasu Kato; Kenji Tamura
Journal:  J Gynecol Oncol       Date:  2018-01       Impact factor: 4.401

10.  Does the extension of the type of hysterectomy contribute to the local control of endometrial cancer?

Authors:  Tetsuya Hasegawa; Megumi Furugori; Kazumi Kubota; Mikiko Asai-Sato; Aiko Yashiro-Kawano; Hisamori Kato; Yuka Oi; Hiroyuki Shigeta; Keiko Segawa; Masakazu Kitagawa; Yuko Mine; Haruya Saji; Reiko Numazaki; Yasuyo Maruyama; Emi Ohnuma; Hanako Taniguchi; Ken Sugiura; Etsuko Miyagi; Tatsuya Matsunaga
Journal:  Int J Clin Oncol       Date:  2019-05-08       Impact factor: 3.402

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.